FDG-PET-CT as an early detection method for tuberculosis: a systematic review and meta-analysis.
18 F-Fluorodeoxyclucose
Computed Tomography
Diagnostic accuracy
Early detection
Positron Emission Tomography
Tuberculosis
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
29 Jul 2024
29 Jul 2024
Historique:
received:
25
07
2023
accepted:
16
07
2024
medline:
30
7
2024
pubmed:
30
7
2024
entrez:
29
7
2024
Statut:
epublish
Résumé
Tuberculosis (TB) causes major public health problems worldwide. Fighting TB requires sustained efforts in health prevention, diagnosis and treatment. Previous literature has shown that conventional diagnostic methods like X-ray and sputum microscopy often miss early or extrapulmonary TB due to their limited sensitivity. Blood tests, while useful, lack the anatomical detail needed for precise localization of TB lesions. A possible step forward in the fight against TB could be the use of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) and Computed Tomography (CT). This meta-analysis discusses the current literature, including the methods, results and implications of using FDG-PET-CT in the early diagnosis of TB. Analysis of the studies showed that the sensitivity of FDG-PET-CT as a potential method for early detection of TB was 82.6%.
Identifiants
pubmed: 39075378
doi: 10.1186/s12889-024-19495-6
pii: 10.1186/s12889-024-19495-6
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Systematic Review
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2022Informations de copyright
© 2024. The Author(s).
Références
Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Tuberculosis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, eds. Major Infectious Diseases 3rd ed. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088.
World Health Organization. Global tuberculosis report 2020. Geneva: WHO; 2020.
Dye C, Williams BG. The population dynamics and control of tuberculosis. Science. 2010;328(5980):856 – 61. https://doi.org/10.1126/science.1185449 . PMID: 20466923.
Zumla A, George A, Sharma V, Herbert N. Baroness Masham of Ilton. WHO’s 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet. 2013;382(9907):1765–7. https://doi.org/10.1016/S0140-6736(13)62078-4 . Epub 2013 Oct 23. PMID: 24269294.
doi: 10.1016/S0140-6736(13)62078-4
pubmed: 24269294
Lawn SD, Zumla AI, Tuberculosis. Lancet. 2011;378(9785):57–72. https://doi.org/10.1016/S0140-6736(10)62173-3 . Epub 2011 Mar 21. PMID: 21420161.
doi: 10.1016/S0140-6736(10)62173-3
pubmed: 21420161
Lönnroth K, Raviglione M. The WHO’s new end TB strategy in the post-2015 era of the Sustainable Development Goals. Trans R Soc Trop Med Hyg. 2016;110(3):148–50. https://doi.org/10.1093/trstmh/trv108 . PMID: 26884490; PMCID: PMC4755423.
doi: 10.1093/trstmh/trv108
pubmed: 26884490
pmcid: 4755423
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H, Gilpin C, Glaziou P, Grzemska M, Mirzayev F, Nakatani H, Raviglione M. For WHO’s global TB Programme. WHO’s new end TB strategy. Lancet. 2015;385(9979):1799–801. https://doi.org/10.1016/S0140-6736(15)60570-0 . Epub 2015 Mar 24. PMID: 25814376.
doi: 10.1016/S0140-6736(15)60570-0
pubmed: 25814376
Desikan P. Sputum smear microscopy in tuberculosis: is it still relevant? Indian J Med Res. 2013;137(3):442–4. PMID: 23640550; PMCID: PMC3705651.
pubmed: 23640550
pmcid: 3705651
Martinez V, Castilla-Lievre MA, Guillet-Caruba C, Grenier G, Fior R, Desarnaud S, Doucet-Populaire F, Boué F. (18)F-FDG PET/CT in tuberculosis: An early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis. 2012;16(9):1180–1185. https://doi.org/10.5588/ijtld.12.0010 . Epub 2012 Jul 12. PMID: 22794271.
Ankrah AO, van der Werf TS, de Vries EF, Dierckx RA, Sathekge MM, Glaudemans AW. PET/CT imaging of Mycobacterium tuberculosis infection. Clin Transl Imaging. 2016;4:131–144. https://doi.org/10.1007/s40336-016-0164-0 . Epub 2016 Mar 7. PMID: 27077068; PMCID: PMC4820496.
Yu WY, Lu PX, Assadi M, Huang XL, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M, Wáng YXJ. Updates on
doi: 10.21037/qims.2019.05.24
pubmed: 31367568
pmcid: 6629575
Vaquero JJ, Kinahan P. Positron emission tomography: current challenges and opportunities for technological advances in clinical and preclinical imaging systems. Annu Rev Biomed Eng. 2015;17:385–414. https://doi.org/10.1146/annurev-bioeng-071114-040723 . PMID: 26643024; PMCID: PMC5299095.
doi: 10.1146/annurev-bioeng-071114-040723
pubmed: 26643024
pmcid: 5299095
Harkirat S, Anana SS, Indrajit LK, Dash AK. Pictorial essay: PET/CT in tuberculosis. Indian J Radiol Imaging. 2008;18(2):141–7. PMCID: PMC2768639.
doi: 10.4103/0971-3026.40299
pmcid: 2768639
Coenen HH, Gee AD, Adam M, et al. Open letter to journal editors on: International Consensus Radiochemistry nomenclature guidelines. Ann Nucl Med. 2018;32:236–8. https://doi.org/10.1007/s12149-018-1238-z .
doi: 10.1007/s12149-018-1238-z
pubmed: 29423765
pmcid: 5852186
Geadas C, Acuna-Villaorduna C, Mercier G, Kleinman MB, Horsburgh CR Jr., Ellner JJ, Jacobson KR. FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study. BMC Res Notes. 2018;11(1):464. https://doi.org/10.1186/s13104-018-3564-6 . PMID: 30001743; PMCID: PMC6044021.
doi: 10.1186/s13104-018-3564-6
pubmed: 30001743
pmcid: 6044021
Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47–55. https://doi.org/10.4046/trd.2015.78.2.47 . Epub 2015 Apr 2. PMID: 25861336; PMCID: PMC4388900.
doi: 10.4046/trd.2015.78.2.47
pubmed: 25861336
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009 . PMID: 22007046.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. https://doi.org/10.1016/0197-2456(86)90046-2 . PMID: 3802833.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. https://doi.org/10.1136/bmj.315.7109.629 . PMID: 9310563; PMCID: PMC2127453.
doi: 10.1136/bmj.315.7109.629
pubmed: 9310563
pmcid: 2127453
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. https://doi.org/10.1002/sim.1186 . PMID: 12111919.
Yen RF, Chen KC, Lee JM, Chang YC, Wang J, Cheng MF, Wu YW, Lee YC. 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging. 2008;35(7):1305–15. Epub 2008 Feb 19. PMID: 18283453.
doi: 10.1007/s00259-008-0733-1
pubmed: 18283453
Kim DW, Park SA, Kim CG. Dual-time-point positron emission tomography findings of benign mediastinal fluorine-18-fluorodeoxyglucose uptake in tuberculosis-endemic region. Indian J Nucl Med. 2011;26(1):3–6. https://doi.org/10.4103/0972-3919.84586 . PMID: 21969771; PMCID: PMC3180718.
doi: 10.4103/0972-3919.84586
pubmed: 21969771
pmcid: 3180718
Kim SJ, Kim IJ, Suh KT, Kim YK, Lee JS. Prediction of residual disease of spine infection using F-18 FDG PET/CT. Spine (Phila Pa 1976). 2009;34(22):2424–2430. https://doi.org/10.1097/BRS.0b013e3181b1fd33 . PMID: 19829257.
Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010;100(9):598–601. https://doi.org/10.7196/samj.4082 . PMID: 20822650.
Kim K, Kim SJ, Kim IJ, Kim BS, Pak K, Kim H. Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis. Nucl Med Commun. 2011;32(12):1155–1161. https://doi.org/10.1097/MNM.0b013e32834bbdf1 . PMID: 21970834.
Li Y, Su M, Li F, Kuang A, Tian R. The value of ¹⁸F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis. Ann Nucl Med. 2011;25(10):804–11. https://doi.org/10.1007/s12149-011-0530-y . Epub 2011 Aug 31. PMID: 21879296.
doi: 10.1007/s12149-011-0530-y
pubmed: 21879296
Kumar A, Dutta R, Kannan U, Kumar R, Khilnani GC, Gupta SD. Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation. Ann Thorac Med. 2011;6(1):11–6. https://doi.org/10.4103/1817-1737.74270 . PMID: 21264165; PMCID: PMC3023864.
doi: 10.4103/1817-1737.74270
pubmed: 21264165
pmcid: 3023864
Lee SH, Min JW, Lee CH, Park CM, Goo JM, Chung DH, Kang CH, Kim YT, Kim YW, Han SK, Shim YS, Yim JJ. Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer. J Korean Med Sci. 2011;26(1):67–70. Epub 2010 Dec 22. PMID: 21218032; PMCID: PMC3012852.
doi: 10.3346/jkms.2011.26.1.67
pubmed: 21218032
Sathekge M, Maes A, Kgomo M, Stoltz A, Van de Wiele C. Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J Nucl Med. 2011;52(6):880–5. https://doi.org/10.2967/jnumed.110.083709 . Epub 2011 May 13. PMID: 215717.
doi: 10.2967/jnumed.110.083709
pubmed: 21571788
Sathekge M, Maes A, D’Asseler Y, Vorster M, Gongxeka H, Van de Wiele C. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease. Eur J Nucl Med Mol Imaging. 2012;39(7):1184–1190. https://doi.org/10.1007/s00259-012-2115-y . Epub 2012 Apr 18. PMID: 22526957.
Fuster D, Tomás X, Mayoral M, Soriano A, Manchón F, Cardenal C, Monegal A, Granados U, Garcia S, Pons F. Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2015;42(2):264–271. https://doi.org/10.1007/s00259-014-2898-0 . Epub 2014 Sep 4. PMID: 25186431.
Werutsky G, Hochhegger B, Lopes de Figueiredo Pinto JA, Martínez-Mesa J, Zanini ML, Berdichevski EH, Vilas E, da Silva VD, Tsukazan MTR, Vieira A, Fritscher LG, Hartmann L, Alba M, Sartori G, Matushita C, Bortolotto V, do Amaral RR, Junior LCA, Zaffaroni F, Barrios CH, Debiasi M, Frietscher CC. PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114). BMC Cancer. 2019;19(1):5. https://doi.org/10.1186/s12885-018-5233-5 . PMID: 30606144; PMCID: PMC6318867.
doi: 10.1186/s12885-018-5233-5
pubmed: 30606144
pmcid: 6318867
Malherbe ST, Chen RY, Dupont P, Kant I, Kriel M, Loxton AG, Smith B, Beltran CGG, van Zyl S, McAnda S, Abrahams C, Maasdorp E, Doruyter A, Via LE, Barry CE 3rd, Alland D, Richards SG, Ellman A, Peppard T, Belisle J, Tromp G, Ronacher K, Warwick JM, Winter J, Walzl G. Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response. EJNMMI Res. 2020;10(1):8. https://doi.org/10.1186/s13550-020-0591-9 . PMID: 32040770; PMCID: PMC7010890.
doi: 10.1186/s13550-020-0591-9
pubmed: 32040770
pmcid: 7010890
Zeng Y, Zhai XL, Wáng YXJ, Gao WW, Hu CM, Lin FS, Chai WS, Wang JY, Shi YL, Zhou XH, Yu HS, Lu XW. Illustration of a number of atypical computed tomography manifestations of active pulmonary tuberculosis. Quant Imaging Med Surg. 2021;11(4):1651–67. https://doi.org/10.21037/qims-20-1323 . PMID: 33816198; PMCID: PMC7930668.
doi: 10.21037/qims-20-1323
pubmed: 33816198
pmcid: 7930668
Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D’Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of
doi: 10.1007/s40336-021-00445-w
pubmed: 34277510
pmcid: 8271312
McDougald W, Vanhove C, Lehnert A, Lewellen B, Wright J, Mingarelli M, Corral CA, Schneider JE, Plein S, Newby DE, Welch A, Miyaoka R, Vandenberghe S, Tavares AAS. Standardization of preclinical PET/CT imaging to improve quantitative accuracy, precision, and reproducibility: a multicenter study. J Nucl Med. 2020;61(3):461–8. Epub 2019 Sep 27. PMID: 31562220; PMCID: PMC7067528.
doi: 10.2967/jnumed.119.231308
pubmed: 31562220
pmcid: 7067528
Gowrishankar G, Namavari M, Jouannot EB, Hoehne A, Reeves R, Hardy J, Gambhir SS. Investigation of 6-[¹⁸F]-fluoromaltose as a novel PET tracer for imaging bacterial infection. PLoS ONE. 2014;9(9):e107951. https://doi.org/10.1371/journal.pone.0107951 . PMID: 25243851; PMCID: PMC4171493.
doi: 10.1371/journal.pone.0107951
pubmed: 25243851
pmcid: 4171493
Zaharchuk G, Davidzon G. Artificial intelligence for optimization and interpretation of PET/CT and PET/MR images. Semin Nucl Med. 2021;51(2):134–142. https://doi.org/10.1053/j.semnuclmed.2020.10.001 . Epub 2020 Nov 11. PMID: 33509370.
Khan RMN, Ahn YM, Marriner GA, Via LE, D’Hooge F, Lee SS, Yang N, Basuli F, White AG, Tomko JA, Frye LJ, Scanga CA, Weiner DM, Sutphen ML, Schimel DM, Dayao E, Piazza MK, Gomez F, Dieckmann W, Herscovitch P, Mason NS, Swenson R, Kiesewetter DO, Backus KM, Geng Y, Raj R, Anthony DC, Flynn JL, Barry CE, Davis BG. Distributable, metabolic PET reporting of tuberculosis. bioRxiv [Preprint]. 2023 Apr 3:2023.04.03.535218. https://doi.org/10.1101/2023.04.03.535218 . PMID: 37333343; PMCID: PMC10274857.
Antunovic L, Rodari M, Rossi P, Chiti A. Standardization and quantification in PET/CT imaging: Tracers beyond FDG. PET Clin. 2014;9(3):259–66. https://doi.org/10.1016/j.cpet.2014.03.002 . Epub 2014 May 6. PMID: 25030389.
doi: 10.1016/j.cpet.2014.03.002
pubmed: 25030389
Zeng X, Peng L, Tan C, Wang Y. Cost-effectiveness analysis of positron-emission tomography-computed tomography in preoperative staging for nonsmall-cell lung cancer with resected monometastatic disease. Med (Baltim). 2019;98(33):e16843. https://doi.org/10.1097/MD.0000000000016843 . PMID: 31415409; PMCID: PMC6831239.
doi: 10.1097/MD.0000000000016843
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54. https://doi.org/10.1007/s00259-014-2961-x . Epub 2014 Dec 2. PMID: 25452219; PMCID: PMC4315529.
doi: 10.1007/s00259-014-2961-x
pubmed: 25452219
Yonekura Y, Tsujii H, Hopewell JW, Ortiz López P, Cosset JM, Paganetti H, Montelius A, Schardt D, Jones B, Nakamura T. Radiological protection in ion beam radiotherapy: practical guidance for clinical use of new technology. Ann ICRP. 2016;45(1 Suppl):138–47. Epub 2016 Mar 15. PMID: 26980799.
doi: 10.1177/0146645316630708
pubmed: 26980799